Biotech

All Articles

Former Seagen CEO introduces new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was actually offered to Pfizer in 2014 for a ...

Ironwood produces further bid for $1B GI medicine with brand new subgroup information

.On the heels of a stage 3 gain that stopped working to wow clients, Ironwood Pharmaceuticals is act...

Novartis inks $150M offer for autoimmune molecular glue

.Do not stop Monte Rosa Therapies currently. The Boston-based biotech is having a ball after signing...

Jade carves out exec team along with Chinook veterinarians-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of notable management hirings, shootings and...

Septerna goes social with upsized offering of $288M

.Commemorating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fi...

AbbVie brings in Richter wealthier, paying for $25M to create invention pact

.AbbVie has actually come back to the source of its antipsychotic goliath Vraylar trying to find ano...

GenSight gets in final full weeks of cash money runway as income flow edges out of reach

.GenSight Biologics is actually full weeks out of losing loan. Once more. The biotech only has adequ...

AZ licenses discarded unusual health condition drug to Monopar Therapies

.Monopar Therapeutics is actually recouping a medicine coming from the dump of AstraZeneca's rare he...

Arcus' brand new HIF-2a data in renal cancer cells hint at potential upper hand over Merck's Welireg, analysts mention

.Along with brand new data out on Arcus Biosciences' speculative HIF-2a prevention, one team of expe...

Roche wagers around $1B to broaden Dyno gene treatment distribution deal

.After developing a gene therapy collaboration with Dyno Rehabs in 2020, Roche is back for more.In a...